Results 21 to 30 of about 161,849 (206)

Pulmonary alveolar proteinosis induced by X-linked agammaglobulinemia: A case report. [PDF]

open access: yesWorld J Clin Cases
BACKGROUND Pulmonary alveolar proteinosis (PAP) and X-linked agammaglobulinemia (XLA) are rare diseases in children. Many theories infer that immunodeficiency can induce PAP, but these reports are almost all review articles, and there is little clinical ...
Zhang T, Li M, Tan L, Li X.
europepmc   +2 more sources

SARS-CoV-2 spike antibody concentration in gamma globulin products from high-prevalence COVID-19 countries are transmitted to X-linked agammaglobulinemia patients. [PDF]

open access: yesFront Immunol, 2023
Purpose Patients with X-linked agammaglobulinemia (XLA) are characterized by humoral impairment and are routinely treated with intravenous immunoglobulin (IVIG).
Raphael A   +11 more
europepmc   +2 more sources

Astrovirus Encephalitis in Boy with X-linked Agammaglobulinemia

open access: yesEmerging Infectious Diseases, 2010
Encephalitis is a major cause of death worldwide. Although >100 pathogens have been identified as causative agents, the pathogen is not determined for up to 75% of cases.
Phenix-Lan Quan   +15 more
doaj   +6 more sources

Infections With Enterohepatic Non-H. pylori Helicobacter Species in X-Linked Agammaglobulinemia: Clinical Cases and Review of the Literature. [PDF]

open access: yesFront Cell Infect Microbiol, 2021
The genus Helicobacter is classified into two main groups according to its habitat: gastric and enterohepatic. Patients with X-linked agammaglobulinemia (XLA) appear to be associated with invasive infection with enterohepatic non-Helicobacter pylori ...
Romo-Gonzalez C   +11 more
europepmc   +2 more sources

Responses to SARS-CoV-2 Vaccines of Patients with Common Variable Immune Deficiencies and X-linked Agammaglobulinemia. [PDF]

open access: yesJ Clin Immunol, 2022
We read with great interest the article by Ane F Salinas et al. [1] concerning early immune responses after BNT162b2 immunization in a cohort of 41 SARS-CoV-2 infectionnaïve or previously infected patients with common variable immune deficiencies (CVID ...
Carrabba M   +4 more
europepmc   +2 more sources

Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant. [PDF]

open access: yesJ Clin Immunol, 2022
Immunodeficient individuals often rely on donor-derived immunoglobulin (Ig) replacement therapy (IGRT) to prevent infections. The passive immunity obtained by IGRT is limited and reflects the state of immunity in the plasma donor population at the time ...
Lindahl H   +9 more
europepmc   +2 more sources

Clinical case of primary immunodeficiency: X-linked agammaglobulinemia

open access: diamondМедицинская иммунология, 2020
Aclinical case ofprimary immunodeficiency state (PIDS) is described: X-linked agammaglobulinemia in the boy of 8 years old. The results of molecular genetic studies: gene btk (ex 1-19) genome version GRCh38.p5, transcript version ENST00000308731 single ...
E. V. Kuvschinova   +4 more
doaj   +3 more sources

Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adults [PDF]

open access: goldRespiratory Research, 2001
Background X-linked agammaglobulinemia (XLA) is a humoral immunodeficiency caused by disruption of the Bruton's tyrosine kinase (BTK) gene. Typical XLA patients suffer recurrent and severe bacterial infections in childhood.
Tsuchiya Shigeru   +7 more
doaj   +2 more sources

Immunologic Control of Disseminated Aichi Virus Infection in X-Linked Agammaglobulinemia by Transplantation of TcRαβ-Depleted Haploidentical Hematopoietic Cells. [PDF]

open access: yesJ Clin Immunol, 2022
We report a rare case of a chronic disseminated Aichi virus infection in a pediatric patient with X-linked agammaglobulinemia (XLA) that was controlled upon HLA-haploidentical hematopoietic cell transplantation (haplo-HCT).
Bekassy Z   +4 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy